Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents the sellers in the sale of Donya Labs to Microsoft.
Mandate

Vinge represents the sellers in the sale of Donya Labs to Microsoft.

January 19, 2017

Microsoft acquires the Linköping based company Donya Labs, developer of the Simplygon software for 3D games and VR applications. Among the sellers are the founders Ulrik Lindahl and Koshi Hamedi as well as SEB Venture Capital.

Vinge's team comprised Johan Larsson (M&A), Ulrich Ziche (M&A), Carl Sander (M&A), Mathilda Persson (Technology) and Niclas Thorgerzon (Technology).

Related

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026

Vinge advises SenzaGen on its acquisition of Alcyomics

 SenzaGen AB (publ) has acquired Alcyomics Ltd. The transaction is being financed through a combination of existing cash and a directed issue of convertible bonds.
November 09, 2026